Experience in Medical Technology

Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients

Sustained Benefits for Patients Awaiting Transplantation ANN ARBOR, Mich., April 7 /PRNewswire/ -- The DuraHeart(TM) Left Ventricular Assist System (LVAS) shows sustained benefits in providing safe and reliable long-term circulatory support with an improved survival rate and an acceptable adv...

First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting

CHESHIRE, Conn., Dec. 7 /PRNewswire-FirstCall/-- Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN ) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), was associated with an improvement in hematologic parameters in a l...

Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care

NEWPORT NEWS, Va., April 29 /PRNewswire/ -- Recently published data in The American Journal of Surgery by a group of surgeons from Legacy Good Samaritan Hospital in Portland, Oregon, demonstrates the value of using Breast-Specific Gamma Imaging (BSGI) for the clinical management of breast canc...

Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent

SPIRIT III Results Demonstrate Superior Reduction in In-Segment Late Loss, Non-Inferiority in Target Vessel Failure and Low Rates of MACE with XIENCE V Compared to TAXUS ABBOTT PARK, Ill., April 22 /PRNewswire-FirstCall/ -- A study published in today's Journal of the A...

Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents

- Researcher Participating in Bavituximab U.S. Cancer Trial Presents Data on Novel Anti-PS Monoclonal Antibody to Anti-Angiogenesis Experts - TUSTIN, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical stage biopharmaceutical company developing...

Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex

- Clinical Trial Data and Emerging Clinical Practice Experience Support HYLENEX Efficacy and Safety - SAN DIEGO, Jan. 8 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products based on the e...

Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies

Study Reveals that Thoracic Endoluminal Grafting is a Feasible Alternative TO Open Surgical Repair J Vasc Surg. 2007 Sep; 46(3):413-20. Application of Endograft to Treat Thoracic Aortic Pathologies: A Single Center Experience. Rodriguez JA, Olsen DM, Shtutman A, Luca...

JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program

PALO ALTO, Calif., March 14, 2007 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. announced today that the Journal of the of Cardiology (JACC) has published data from the Ranolazine Open Label Experience (ROLE) program, which showed long-term therapy with Ranexa(R) (ranolazine extended-release tab...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...mely heterozygous FH patients. This strategy ensures that mipomersen will reach the patients who need the drug the most first, and provide commercial experience with mipomersen as we broaden our indication to larger patient populations, such as heterozygous FH patients. We have now completed enrollment in the...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... of symptoms that interfere with a person's ability to work, sleep, study, eat, and enjoy once-pleasurable activities. Approximately 8% of adults will experience major depression at some time in their lives. About Labopharm Inc. Labopharm is an emerging leader in optimizing the performance of existing...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

...hange over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the Company's ability to progress any product candidates in preclinical or clinical trials; the scope, init...

2,500 Cases Completed With the Magnetic Irrigated Catheter

...hythmias in all four chambers of the heart and across a broad spectrum of patients ranging from pediatric to geriatric. Included in the Niobe clinical experience are several very compelling procedures in patients with congenital heart defects and patients with peripheral vascular occlusive disease. Altogether ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

...timated to be $12.6 billion last year.(3) Patients with bone metastases who experience an SRE incur significantly higher medical costs compared with those who do not experience an SRE.(4) About Amgen Amgen discovers, develops and delivers ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...eatment that includes continuous, long-term therapy with antipsychotic medications.(1) Unfortunately, 80 percent of patients with schizophrenia experience at least one relapse within five years of diagnosis(2), and the risk for relapse in patients can substantially increase as a result of non-adherence.(...

Covance Receives Highest Level of Phase I Accreditation

...Rob Aspbury, M.D., managing director, clinical research services, Covance. "As an industry leader in clinical pharmacology, Covance provides superior experience and expertise in study design and conduct to support today's increasingly complex first-in-human trials." MHRA accreditation was introduced t...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... of the patients with bipolar disorder who recover in response to treatment experience recurrence two years later. Patients may experience a high rate of failure due to lack of efficacy or side effects, including m...

New Powder Speeds Healing of Difficult Foot Wounds

...octors of podiatric medicine (DPMs). DPMs are podiatric physicians and surgeons, also known as podiatrists, qualified by their education, training and experience to diagnose and treat conditions affecting the foot, ankle and structures of the leg. The medical education and training of a DPM includes four years ...

Is Your Hair Taking a Break?

...ne in Winston-Salem, N.C., discussed the different types of hair loss women experience and the current treatment options. "Hair loss is a very misundersto...in patches of bald spots. However, she cautioned that not all patients will experience hair regrowth even with treatment -- which could have a significant negativ...

Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin

...asticity. During pregnancy when estrogen levels are at their highest, women experience thicker hair and glowing skin. On the other hand, post-menopausal women may...enopause -- and did not wait to start treatment like the other group -- did experience noticeable improvements in their skin," said Dr. Parsons. "These studies po...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

... million Americans are estimated to have low bone mass, placing them at increased risk for osteoporosis(10) Half of women over 50 in the US will experience an osteoporosis-related fracture in her lifetime(11) The impact of breaking a bone is significant and often leads to a downward spiral for the p...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

...d States are of menopausal age (45 to 64 years). Of these women, 17 million experience vasomotor symptoms; 9 million experience moderate to severe symptoms. Menopause is different for every woman, and va...

Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care

... restoration and maintenance of circulating blood volume. Based in Lachen, Switzerland, Octapharma employs over 3,000 people and has biopharmaceutical experience in 80 countries worldwide, including the United States, where Octapharma USA is headquartered in Hoboken, N.J. Octapharma operates two state-of-th...

Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)

... failure. Talk to your doctor immediately if you experience unusually fast weight gain, fluid retention (swell...thereafter. Talk to your doctor immediately if you experience nausea, vomiting, stomach pain, tiredness, loss of... for low blood sugar. Some people taking ACTOS may experience flulike symptoms, mild-to-moderate swelling of leg...

July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bell's Palsy and Heart Valve Repair

...rrow pathway. The result is Bell's palsy. Symptoms include: Abrupt weakness or limpness on one side of the face (Most people don't experience total paralysis.) A dry, irritated eye with tears dripping from the corner Pain around the ear or jaw, ringing in the ears, sensitivity to...

Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

... product over the past few years as it's easy to administer and the patient experience is similar to temporary fillers on the market today." This simple,... trained and select few company sponsored physicians who has the skills and experience needed to administer the product. Stephanie C., a patient of D...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

...bacterial delivery system that will promote intestinal repair and restore the balance of normal microbiota. Dr. Kolling's work could help patients who experience antibiotic-associated diarrhea (AAD) after receiving antibiotic treatment. The other grant will be awarded to Xinhua Chen, PhD, who is an Ins...

New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed

...s of skin and liver problems. VIRAMUNE should be discontinued and not restarted in patients who have any of these reactions. Any patient can experience liver problems with VIRAMUNE, but women and patients who have higher CD4+ counts when they begin VIRAMUNE treatment have a greater risk. A woman with ...

Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease

...stment and relocation to Pittsburgh, the company secured Dr. Hank Safferstein as President and CEO, bringing with him more than 15 years of leadership experience in drug development, commercialization and marketing for a number of public and private companies. www.cogrx.com . About Ogden ...

Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing

... edoxaban as a potential new treatment for the prevention of both arterial and venous thromboembolism. Notably, Daiichi Sankyo has more than 25 years experience conducting research in the area of Factor Xa inhibition, and was the first company to test these compounds in humans. Daiichi Sankyo is acti...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

... may offer benefits for cognition in late life. We need more research before we can confidently say how much of these foods to include in your diet to experience some benefit. Two studies from ICAD 2009 looked at physical activity and mental performance as we age. One study found that maintai...

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

...reatments have resulted in an overall decline in mortality and increased survival, approximately half of all children with malignant solid tumors will experience relapse and, of these children, less than 10% will achieve long-term survival after standard multimodal therapy. About Keryx Biopharmaceutic...

Dry Mouth Linked to Prescription and Over the Counter Drugs

...re teeth) are also dry mouth symptoms. Over time, xerostomia sufferers may experience extensive tooth decay, tooth loss or gingivitis (gum disease) due to the la...nt for patients to discuss symptoms with their dentist, even if they do not experience them on the day of the office visit." The AGD reports a number of act...

FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)

...en of Dacogen(R) submitted to the U.S. FDA is a single daily dose with a significantly reduced administration time. If approved, patients with MDS may experience increased convenience with the new dosing regimen. "We're pleased that the FDA has agreed to review our application for the alternative dosing r...

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases

...timated to be $12.6 billion last year.(3) Patients with bone metastases who experience an SRE incur significantly higher medical costs compared with those who do not experience an SRE.(4) About Amgen Amgen discovers, develops and delivers in...

Neuroscience Researcher Has Positive Message for International Alzheimer's Awareness Week, July 6 - 12: 'Even Though World Economy is Declining, Alzheimer's Research is Advancing'

...e their own calcium-binding proteins but we gradually stop producing them at about age 40, and that's when our neurons start to weaken and we begin to experience mild memory loss," says Underwood. "Those with Alzheimer's apparently stop producing these proteins at a faster rate so their cognitive impairment oc...

Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets

... and severity of disease. UC causes flares followed by periods of remission. During a flare, in which the rectum or colon become inflamed, people experience symptoms such as diarrhea, rectal bleeding, abdominal cramping and an urgent need to go to the bathroom. Flares can vary in duration and intensity. Wh...

Relievant Medsystems Announces Completion of $20 Million Financing

...n Partners and ONSET Ventures have shown in our technology and team. Their experience will help us build a great company." About Relievant Medsystems Re...e and healthcare companies. Emergent's partnership has over fifty years of experience creating and investing in medical devices and healthcare companies with a f...

New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation

...ence indicating whether the procedure reduces the chance that patients will experience atrial fibrillation over the long term. The report, which compared ra...roval registry, which will collect safety (adverse event) data and operator experience information through 7 days post-treatment with the approved ablation cathet...

Number of Patients With Dementia on the Rise

...rticipate in U-M sponsored research designed to better diagnose and treat dementia before it escalates. Sabin is one of millions of Americans who experience memory loss and may eventually be diagnosed with dementia. "This is an explosive disease," says Sid Gilman, M.D., director of the Alzheimer's Dis...

Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value

...certain other medicines should tell their doctors because serious stomach problems, such as bleeding, may get worse. Some people who take Aricept may experience fainting. Some people may have nausea, vomiting, diarrhea, bruising, or not sleep well. Some people may have muscle cramps or loss of appetite or may...